Press Release

KIKA™ Clinical Solutions announced the availability of Veracity™ 3.8, the latest version of its innovative EDC solution. KIKA is the leading provider of advanced EDC solutions for Clinical Asset Management™ for the pharmaceutical, biotechnology and medical device markets.

KIKA CEO Linda Beneze commented, “Veracity™ 3.8 reflects KIKA’s total commitment to providing the industry’s most innovative, reliable, flexible EDC technology. Veracity™ is the only EDC solution that enables sponsors to completely protect, control and maximize their most important clinical trial asset – their data.”

Key new functionality in Veracity™ 3.8 includes:

• Improved Endpoint Adjudication – Veracity™ already leads the EDC industry in endpoint adjudication capabilities. Enhancements in Veracity™ 3.8 provide an even better user experience with new tools that enable advanced endpoint adjudication workflow. The enhancements also facilitate the work of the endpoint processing and review manager, and ensure a faster and easier decision making process.
• Enhanced Data Audit Trail – Now directly available through the Veracity™ Web client, this new feature version eases the daily tasks of the clinical trial Monitor and Data Manager. The Data Audit Trail tracks and reviews every action performed on the clinical data. It allows global query capabilities on the entire study. It filters and sorts capabilities, displays all useful information (such as author, timestamp, type of actions, old value and new value, hyperlink to the relevant element, etc.).
• Automated Query – This new extension to the existing module of manual monitoring query saves Monitors time. For a defined criteria (out of ranges values, missing data, etc.) Veracity™ can initiate the manual query process by automatically posting the query to the site. This frees Monitors from having to spend time on this repetitive action.
• New Language Support – The Veracity™ user interface now is natively supported in Italian and Spanish. Other supported languages are English, French and German.

Several other improvements provide a better end user experience. Additionally, authoring tools enhancements include easier implementation of the signature workflow, the monitoring query workflow, and the SDV workflow.

Announcing New Webinar: “The Next Generation of EDC.”

On March 23 KIKA and Accuray Incorporated (Nasdaq: ARAY) will conduct a Webinar, “The Next Generation of EDC.” Attendees will learn how making the monitoring function more efficient improves the quality of the site visit; how the reporting tools in EDC systems make it easier to see the status of the trial from multiple perspectives; and how to attach images to the Case Report Form to boost the value of the CRF contents. To register, email sales@kika-cs.com.

About KIKA Clinical Solutions

KIKA helps the world's most innovative biopharmaceutical and medical device organizations use advanced EDC solutions to bring much-needed medical solutions to market faster. KIKA’s Veracity™ is the leading-edge Web-based clinical trial software platform that delivers Clinical Asset Management™ for any size clinical trial. Veracity™ meets study needs precisely. It provides unmatched flexibility and customization with advanced EDC including images and online adjudication. Veracity™ is backed by the industry’s most reliable IT infrastructure and a world class Professional Services organization. For more information, visit www.kikaclinicalsolutions.com.

KIKA, Veracity and Clinical Asset Management are trademarks of the KIKA group of companies.

Become a fan of KIKA Clinical Solutions on Facebook and follow KIKAClinical on Twitter.

Last updated on: 27/08/2010 11:40:18